F. Homans

Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

Neil B. Doherty, John O. Prior, Jeffrey T. Huffman, 2021, JACC. Asia.

Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy

A. Maes, O. Hoekstra, R. de Bree, 2022, EJNMMI Research.

International Impact of COVID-19 on the Diagnosis of Heart Disease

John O. Prior, Jeffrey T. Huffman, L. J. Shaw, 2021, Journal of the American College of Cardiology.

Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

C. S. Low, Katarina H. Nelson, James L. Streeter, 2022, Journal of the American College of Cardiology.

Early response monitoring with FDG-PET in a phase I study in metastatic breast cancer

P. Dupont, L. Mortelmans, I. Vergote, 1999 .

Ga-67-positive and F-18 FDG-negative imaging in well-differentiated hepatocellular carcinoma.

A. Maes, L. Mortelmans, P. Flamen, 2001, Clinical nuclear medicine.

Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET).

L. Mortelmans, A. Maes, L. Mortelmans, 2001, European journal of cancer.

Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: results from the ECLYPS study

A. Maes, O. Hoekstra, R. de Bree, 2020, European Journal of Nuclear Medicine and Molecular Imaging.